Singapore, June 19 -- When the BIO International Convention opens in San Diego on 22 June, the Italian National Pavilion will arrive carrying an unusually confident set of numbers. In 2025, Italian pharmaceutical exports to the United States reached €15.7 billion - a 54% jump on the previous year that cements the US as the single largest destination for Italian medicines. For an Asia-Pacific industry that has spent the past decade arguing about where the world's drugs will actually be made, that figure is more than a European footnote. It is a signal about where contract capacity, regulatory know-how and partnering momentum are pooling.

Organised by the Italian Trade Agency (ITA) with the country's foreign-affairs and enterprise mi...